Insider tradingForm 4
Xenon Pharmaceuticals Inc. (XENE) Insider Trading
4 open-market trades reported since Aug 13, 2026: 2 purchases worth $1.68M and 2 sales worth $1.07M.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Ian Mortimer | CEO | 1 | $1.12M | 0 | $0 |
| Thomas Patrick Kelly | CFO | 1 | $560K | 0 | $0 |
| Christopher John Kenney | Chief Medical Officer | 0 | $0 | 1 | $426K |
| Steven Gannon | Director | 0 | $0 | 1 | $641K |
ADVERTISEMENT
320 × 100 ad slot
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Oct 1 | Ian MortimerCEO | ▲ BUY | $1.12M | |
| Oct 1 | Thomas Patrick KellyCFO | ▲ BUY | $560K | |
| Aug 31 | Christopher John KenneyChief Medical Officer | ▼ SELL10b5-1 | $426K | |
| Aug 13 | Steven GannonDirector | ▼ SELL | $641K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings